• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Myze launches platform to engage 1 million dry eye patients by 2025: How Do Your Eyes Feel?


Leading U.S. eye care experts advance eye health focused digital platform designed to make eye care part of daily self-care routine.

Myze is a next generation eye care engagement platform that helps identify, treat, and manage dry eyes throughout a patient’s dry eye journey.

According to the news release, Myze enables “always available” screenings followed by frictionless access to products, services, and education. No more product overload and decision paralysis at retail locations. Myze makes treating dry eye easy, affordable, and sustainable for patients and their providers.

Currently, at least 16 million people in the United States have been diagnosed with dry eye disease of whom only 10% are being treated. And, as many as 75 million+ more may be suffering from dry eye disease or digital eye strain but have not yet been diagnosed. Dry eye is a chronic, often progressive disease that manifests early on with patient complaints of tired, red, itchy, or gritty eyes. As the disease progresses, blurred vision and potentially loss of vision can occur if not treated and managed properly. It is the #1 reason why patients see eye doctors.

Future MYZE customers will be met through partner physicians, social media, search, and other digital media channels and engaged through a very simple, yet provocative question—"How Do Your Eyes Feel?”

Users engaging with the platform will find immediate and long-term relief for their symptoms and discomfort and will do so through the MYZE suite of customized products and services.

“As physicians, we are seeing and hearing from more dry eye patients than ever before,” said Cynthia Matossian, MD, president of the American College of Eye Surgeons and chair of the Myze Medical Advisory Board.

“Throughout a combination of digital and human interventions, Myze will deliver magical moments and memorable experiences for our customers so they can achieve the best possible outcomes for their dry eyes and other ocular surface issues, Scott Tannenbaum, founder of Myze, said in the press release.

This will be achieved through a data driven dry eye screening solution that provides access to personalized, affordable, and sustainable treatment options, disease state education, and ongoing tracking and engagement, as well as access to the country’s most influential eye care professionals. Marketing technology and machine learning will also power timely reminders, daily inspiration, and ongoing support.

“After spending most days and nights staring at my laptop and phone, my eyes typically feel worn out by the end of the day. After engaging with the MYZE platform, I came to clearly understand why they hurt and how I can treat them,” Lexi, a 35-year-old computer programmer said in the news release. “”The process was easy and simple and the Myze recommended product selections were perfect for my situation.”

For information, visit Helpmyze.com.

Related Videos
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
Tips for better contract negotiations for young ophthalmologists
© 2024 MJH Life Sciences

All rights reserved.